Skip to main content
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. logo

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. — Investor Relations & Filings

Ticker · 000661 ISIN · CNE0000007J8 LEI · 300300X04OTKZG18WD66 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2019-11-10 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000661

About CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.

https://ccht.jl.cn

CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. is a diversified enterprise primarily focused on the research, development, production, and distribution of biopharmaceuticals and healthcare products. The company operates through several key subsidiaries, most notably GeneScience Pharmaceuticals, which specializes in recombinant human growth hormones and pediatric endocrinology treatments. Its product portfolio includes biological drugs, vaccines, and traditional Chinese medicines, targeting therapeutic areas such as growth disorders, infectious diseases, and oncology. The group emphasizes technological innovation and maintains a significant presence in the domestic market while expanding its international footprint. In addition to its core life sciences business, the company maintains interests in real estate development and infrastructure management.

Recent filings

Filing Released Lang Actions
中信建投证券股份有限公司、中天国富证券有限公司关于公司发行股份及可转换债券购买资产并募集配套资金暨关联交易之独立财务顾问报告
Capital/Financing Update Classification · 95% confidence The document is titled as an "Independent Financial Advisor Report" related to the issuance of shares and convertible bonds for asset acquisition and fundraising, including related party transactions. It is prepared by independent financial advisors for a major asset restructuring transaction involving a listed company. The content includes detailed sections on transaction background, asset valuation, financial data, legal compliance, and advisor opinions. The document is comprehensive and lengthy (15,000 characters), containing substantive financial and transaction analysis, not merely an announcement or summary. It is not a general annual report, earnings release, or management discussion but a specialized advisory report related to a major asset restructuring and financing transaction. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, especially involving issuance of shares and convertible bonds for asset purchase and related party transactions.
2019-11-10 Chinese
发行股份及可转换债券购买资产并募集配套资金暨关联交易报告书
Capital/Financing Update Classification · 95% confidence The document is titled as a report on "发行股份及可转换债券购买资产并募集配套资金暨关联交易报告书" which translates to "Issuance of Shares and Convertible Bonds to Purchase Assets and Raise Supporting Funds and Related Party Transaction Report." It includes detailed sections such as transaction overview, related party transactions, major asset restructuring, financial data, risk factors, management discussion and analysis, and opinions from independent directors and financial advisors. The document is lengthy (15,000 characters) and contains substantive financial data, analysis, and legal compliance statements. It is not a brief announcement or a certification but a comprehensive report on a capital raising and asset acquisition transaction involving issuance of shares and convertible bonds. This fits the category of Capital/Financing Update (CAP) as it relates to fundraising activities and capital structure changes. Therefore, the document should be classified as CAP with high confidence.
2019-11-10 Chinese
关于发行股份及可转换债券购买资产并募集配套资金暨关联交易报告书修订说明的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the issuance of shares and convertible bonds to purchase assets and raise supporting funds, including revisions to a related transaction report. It references approval from the China Securities Regulatory Commission and details about the transaction and risk factors. The document is relatively short (979 characters) and serves as a public announcement of the transaction and report revisions rather than the full report itself. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2019-11-10 Chinese
关于发行股份、可转换公司债券购买资产并募集配套资金获得中国证监会核准批文的公告（更新后）
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Changchun High-tech Industry Group Co., Ltd. regarding the approval by the China Securities Regulatory Commission (CSRC) for the issuance of shares and convertible bonds to purchase assets and raise supporting funds. It details the approval of share issuance, convertible bonds, and fundraising limits, along with compliance and disclosure obligations. The content focuses on capital raising activities and regulatory approval rather than presenting financial statements or detailed financial results. The document length is short (966 characters) and is an announcement of regulatory approval rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP).
2019-11-07 Chinese
更正公告
Capital/Financing Update Classification · 95% confidence The document is a correction announcement related to a previous announcement about the issuance of shares and convertible bonds for asset purchase and fundraising. It corrects the amount of fundraising approved by the China Securities Regulatory Commission. The document is short (660 characters) and serves to amend a prior capital/financing update announcement. It does not contain financial statements or detailed financial data, nor is it a full report. Therefore, it is best classified as a Capital/Financing Update (CAP).
2019-11-07 Chinese
关于控股公司使用部分暂时闲置自有资金购买理财产品的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Changchun High-tech Industry (Group) Co., Ltd. regarding the progress of its controlling company's use of temporarily idle funds to purchase financial products. It details the types of financial products purchased, amounts, dates, risk assessments, and risk control measures. The document is a formal disclosure to shareholders and the public about investment activities and risk management related to the company's idle funds. It does not contain comprehensive financial statements, quarterly or annual financial results, nor is it a transcript or presentation. It is not a report publication announcement since it contains substantive information about the investment activities themselves. The document fits best into the category of a Regulatory Filing (RNS) as it is a regulatory announcement about financial activities that do not fall under other specific categories such as earnings release, capital update, or management report.
2019-11-07 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.